DD202147A5 - Verfahren zur herstellung von phenylpiperidinen - Google Patents

Verfahren zur herstellung von phenylpiperidinen Download PDF

Info

Publication number
DD202147A5
DD202147A5 DD82238658A DD23865882A DD202147A5 DD 202147 A5 DD202147 A5 DD 202147A5 DD 82238658 A DD82238658 A DD 82238658A DD 23865882 A DD23865882 A DD 23865882A DD 202147 A5 DD202147 A5 DD 202147A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
group
carbon atoms
acid addition
pharmaceutically acceptable
Prior art date
Application number
DD82238658A
Other languages
German (de)
English (en)
Inventor
Folke-Lars E Arvidsson
Per A E Carlsson
Ilrgen A B Engel
Uli A Hacksell
John St M Hjorth
Per L Lindberg
Anie H Mattsson
John L G Nilsson
Domingo Sanchez
Nils U El Svensson
Hakan V Wikstroem
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DD202147A5 publication Critical patent/DD202147A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD82238658A 1981-04-01 1982-04-01 Verfahren zur herstellung von phenylpiperidinen DD202147A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8102076 1981-04-01

Publications (1)

Publication Number Publication Date
DD202147A5 true DD202147A5 (de) 1983-08-31

Family

ID=20343488

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82238658A DD202147A5 (de) 1981-04-01 1982-04-01 Verfahren zur herstellung von phenylpiperidinen

Country Status (11)

Country Link
EP (1) EP0062018A1 (fr)
JP (1) JPS57175163A (fr)
KR (1) KR830010070A (fr)
AU (1) AU8217182A (fr)
DD (1) DD202147A5 (fr)
DK (1) DK146682A (fr)
FI (1) FI821072L (fr)
GR (1) GR75933B (fr)
NO (1) NO821075L (fr)
PT (1) PT74683B (fr)
ZA (1) ZA821888B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770658B2 (en) 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123743C (fr) * 1963-09-18
FR2310762A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives n-substitues de la phenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Also Published As

Publication number Publication date
PT74683B (en) 1985-01-08
JPS57175163A (en) 1982-10-28
AU8217182A (en) 1982-10-07
PT74683A (en) 1982-04-01
FI821072A7 (fi) 1982-10-02
ZA821888B (en) 1983-02-23
FI821072L (fi) 1982-10-02
KR830010070A (ko) 1983-12-26
GR75933B (fr) 1984-08-02
FI821072A0 (fi) 1982-03-26
NO821075L (no) 1982-10-04
DK146682A (da) 1982-10-02
EP0062018A1 (fr) 1982-10-06

Similar Documents

Publication Publication Date Title
EP0004952B1 (fr) Spiro(dihydrobenzofuranne-pipéridines et -pyrrolidines) et leurs dérivés, procédés pour leur préparation et médicaments les contenant
DE2542881C3 (de) Razemische oder optisch aktive Benzylalkoholderivate, Verfahren zu ihrer Herstellung und sie enthaltende therapeutische Zubereitung
DE2851435A1 (de) Substituierte amid-derivate des l- und dl-phenylglycins, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE2317710A1 (de) Dopaminderivate
DE2020864B2 (de) p-Substituierte 1-Phenoxy-3-alkylaminopropan-2-ole, Herstellungsverfahren und Arzneimittel
DD145265A5 (de) Verfahren zur herstellung von phenethanolaminen
CH372667A (de) Verfahren zur Herstellung von 3-Aryl-3-pyrrolidinolen
DE2656088C2 (de) Benzylalkoholderivate, Verfahren zu deren Herstellung und pharmazeutisches Mittel auf deren Basis
DE3204960A1 (de) Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CH618417A5 (en) Process for the preparation of novel hydroxyamines
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen
DE2522218C3 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
CH640507A5 (en) Process for preparing novel 1-aryloxy-2-hydroxy-3-aminopropanes
DD202147A5 (de) Verfahren zur herstellung von phenylpiperidinen
DE2653147A1 (de) Tetrahydropyridin- und pyperidinderivate und verfahren zu ihrer herstellung
DD202148A5 (de) Verfahren zur herstellung von phenylperhydroazepinen
DE2810482C2 (de) 1-Phenyl-2- eckige Klammer auf (N-alkyl)-amino eckige Klammer zu -propan-1,3-diole, Verfahren zur Herstellung derselben und solche enthaltende Arzneimittel
DD144764A5 (de) Verfahren zur herstellung von r-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylaminen
DE2824291A1 (de) Neue benzylalkoholderivate und verfahren zu ihrer herstellung
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
DE1793799C2 (de) 1 -Phenoxy^-hydroxyO-alkylaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT360018B (de) Verfahren zur herstellung des neuen 4-(7-brom-5 -methoxy-2-benzofuranyl)- piperidins und seiner saeureadditionssalze
CH643536A5 (de) Alkanolaminderivate.
DE2004354C3 (de) Phenäthanolaminäther, Verfahren zu Ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1643237C3 (de) Kernsubstituierte 1-Nitrilophenoxy-3-tert.-butylamino-2-propanole, Verfahren zu deren Herstellung und pharmazeutische Präparate auf deren Basis